home   |   contact us   |   sitemap     

 
   about Formula Pharmaceuticals  technology  pipeline NewsCareers  
   
   
             
   
Overview


Management

 


Board of Directors

 


Advisory Committee

 


Scientific Advisory Board

 


Business Development  

 

 

 

 

Formula Pharmaceuticals, Inc. is a privately-held, oncology focused company developing unique Chimeric Antigen Receptor (“CAR”) immunotherapies to address critical unmet medical needs in cancer. Distinctive from existing CAR-T approaches, Formula leverages an ALLOGENEIC source, NON-viral tranfection and a differentiated immune effector cell, called Cytokine Induced Killer (C.I.K.) cell. Formula has assembled a world-class scientific, clinical development and business team well positioned to maximize the clinical and commercial value of promising drug candidates through excellence in drug development and strategic partnering.